GUIDE
to
xyntha
CLOSE

GUIDE TO
XYNTHA

Guide

Download Arrow

Download
GUIDE TO XYNTHA
as PDF

TRACK
YOUR
BLEEDS

THE TRACKER FACTORy

Iphone5s Pfizer has created a web app called TRACKER FACTORy that’s especially designed for recording infusions as well as bleeds.

You can access this program by simply typing in www.trackerfactory.co.nz to any web enabled device such as your phone, iPad or desktop computer.

Apart from making it really easy to track bleeds and infusions, the data you enter is sent directly to your haemophilia nurse, so they can analyse patterns, trends or anomalies that can help to improve your care.

Other useful features include:

  • Infusions schedules
  • 3-D model for recording of bleeds
  • Messaging capability
  • Appointments diary
  • Emergency button
  • Emergency contacts
  • Secure login system

Staying on track.

When you or your child has haemophilia, there can be a lot to remember about the condition and treatment.

You will give yourself the best chance of treatment success by following a few simple rules:

Always use XYNTHA as instructed.

Your doctor/Haemophilia Treatment Centre will have recommended a dose and treatment routine that is right for you.

Always have enough factor to meet your needs.

Do regular stocktakes/rotations to be aware of how many in-date vials are left, and order more if required.

Stay in touch with your Haemophilia Treatment Centre.

It is your main link to managing your condition and it is there to support you.

XYNTHA (moroctocog alfa (rch) (recombinant coagulation factor VIII))
250 IU, 500 IU, 1000 IU, 2000 IU, 3000 IU

XYNTHA (moroctocog alfa (rch)) is a funded medicine that is prescribed by a doctor for the control and treatment of bleeding and the routine and surgical prevention of bleeding in patients with haemophilia A. A pharmacy charge and normal doctor’s fees apply. Xyntha has risks and benefits. XYNTHA contains trace amounts of hamster protein. You may develop an allergic reaction to these proteins. Tell your doctor if you have had an allergic reaction to hamster protein or any of the other ingredients of XYNTHA. XYNTHA must be used with caution in certain people, including: people with factor VIII inhibitors, people with allergies, people changing from other factor VIII medicines to XYNTHA, and pregnant or breastfeeding women. Ask your doctor for advice. Uncommon to very rare serious side effects include numbness, chest pain, rapid or irregular heartbeat, shortness of breath, bleeding and low blood pressure. If you have side effects see your doctor. If you suddenly experience a swollen face, lips, tongue or throat, shortness of breath, chest tightness, wheezing, dizziness, faintness, chills, flushing, tiredness, restlessness, nausea, vomiting, rapid heartbeat, headache, tingling, burning and stinging at the injection site, hives or skin rash, STOP taking XYNTHA and seek urgent medical attention. These may be signs of a serious allergic reaction. Tell your doctor immediately if you are using increasing amounts of XYNTHA in order to control a bleeding episode. Use strictly as directed. Consult your doctor to see if XYNTHA is right for you. Contains moroctocog alfa (rch) 250, 500, 1000, 2000, 3000 IU/vial or syringe.

Further information on XYNTHA is available from www.medsafe.govt.nz or Pfizer New Zealand Limited, Auckland, www.pfizer.co.nz. Ph. 0800 736 363. V11216 Pfizer New Zealand, Level 1, Suite 1.4, Building B, 8 Nugent Street, Grafton, Auckland 1023. PPZR0332 PP-XYN-NZL-0063, NA 9403 09/17.

XYNTHA® is a registered trademark.
© Pfizer 2017

www.medsafe.govt.nz

www.haemophilia.org.nz

© 2017 Pfizer New Zealand Limited, Auckland. All rights reserved.

Privacy Policy  |  Legal Policy